Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.
HAYWARD, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--#ADC--Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio, Inc. to secure a class of novel proprietary payloads with a wide range of potencies.Aarvik has an exclusive license to commercialize the novel proprietary payloads from NJ Bi...